Thyrocare Technologies Ltd THYROCARE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 644.15
- Day Range
- INR 615.00–645.80
- 52-Week Range
- INR 448.00–722.65
- Bid/Ask
- INR 629.05 / INR 631.05
- Market Cap
- INR 33.42 Bil
- Volume/Avg
- 48,167 / 108,654
Key Statistics
- Price/Earnings (Normalized)
- 41.44
- Price/Sales
- 6.10
- Dividend Yield (Trailing)
- 2.85%
- Dividend Yield (Forward)
- —
- Total Yield
- 2.85%
Company Profile
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Other. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company primarily earns majority of its revenue from Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,645
- Website
- https://www.thyrocare.com
Comparables
Valuation
|
Metric
|
THYROCARE
|
543328
|
688656
|
|---|---|---|---|
Price/Earnings (Normalized) | 41.44 | 33.33 | 35.29 |
Price/Book Value | 6.87 | 2.41 | 1.92 |
Price/Sales | 6.10 | 3.24 | 4.03 |
Price/Cash Flow | 26.25 | 17.33 | 14.84 |
Price/Earnings
THYROCARE
543328
688656
Financial Strength
|
Metric
|
THYROCARE
|
543328
|
688656
|
|---|---|---|---|
Quick Ratio | 2.34 | 1.62 | 1.01 |
Current Ratio | 3.05 | 1.85 | 1.81 |
Interest Coverage | 24.71 | 6.21 | 21.54 |
Quick Ratio
THYROCARE
543328
688656
Profitability
|
Metric
|
THYROCARE
|
543328
|
688656
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | 4.79% |
Return on Equity (Normalized) | — | — | 5.68% |
Return on Invested Capital (Normalized) | — | — | 5.34% |
Return on Assets
THYROCARE
543328
688656
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Ghbnkqdmz | Zcbnr | $218.5 Bil | |
DHR
| Danaher Corp | Gwtbwzmnc | Vcmnh | $184.0 Bil | |
A
| Agilent Technologies Inc | Hknzyxmyx | Mcnpr | $40.9 Bil | |
IQV
| IQVIA Holdings Inc | Yqqbyvb | Kyvqdd | $40.7 Bil | |
IDXX
| IDEXX Laboratories Inc | Nvbcqnxgd | Dwvwwh | $39.7 Bil | |
MTD
| Mettler-Toledo International Inc | Mfffblvgwh | Hswjl | $26.8 Bil | |
ICLR
| Icon PLC | Rxywkwkb | Vtsqml | $25.6 Bil | |
WAT
| Waters Corp | Lydvrwqhk | Hvdcf | $19.1 Bil | |
ILMN
| Illumina Inc | Hzfdcbz | Kpwbqy | $18.8 Bil | |
LH
| Laboratory Corp of America Holdings | Mhvtcxzhk | Hmwmfw | $17.0 Bil |